You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.
It is possible that some of the products on the other site are not approved in your region or country.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations.
Click “OK” to confirm you are a Healthcare Professional.
The sophisticated technology of autoLog IQ™ differentiates itself from other transfusion systems thanks to its effective Dynamic Cell Salvage that provides simplicity of operation in recovering high-quality washed autologous blood.
The autoLog IQ™ has been developed with the possibility to make automatic micro adjustments during treatment to maximize hematocrit and washout* and minimize waste.
It has a small footprint that can be adapted to all spaces for different types of pre and postoperative use (OR / ICU). Its outstanding 20-micron filtration performance of the blood collection Cardiotomy Reservoir, which separates the blood from the smallest bone splinters and embolic particles, and the 135ml bowl size make it perfect for all orthopedic surgeries even for the collection of a small volume of blood.
The vacuum regulation is adjustable in steps of 10 mmHg for wound cavity regular aspiration during peri and post operative period in the operating theaters and in the ICU.
The washout performance†‡ removes more than 95% of all contaminants. This includes the in-standard mode which reduces 99% of fatty acids, leading to a low level of white cells and the PFH. This significantly decreases the complement activation and inflammatory response of the treated patients.
As clinical and financial factors drive greater scrutiny of blood usage, the use of autotransfusion is growing throughout the hospital.1-4
Over the past few decades a number of factors have converged to turn blood use and blood conservation into matters that hospital administrators and medical professionals must urgently addressG Shulman 1, M J Grecula, A G Hadjipavlou
Blood is a SCARCE resource, Blood is an EXPENSIVE resource, Transfusion is associated with POOR outcomes.
Application of interventional blood conservation may circumvent the need for transfusionA. Shander, H. Van Aken, M. J. Colomina, H. Gombotz, A. Hofmann, R. Krauspe, S. Lasocki, T. Richards, R. Slappendel and D. R. Spahn
The development of strategy incorporating autotransfusion management allows your team to adapt to all pre and post operatory situations that may arise during surgery. The autoLog IQ™ provides your team with the device with the smallest footprint allowing you to adapt in all situations.
In pre and post operative situations:
Compared to allogeneic blood
Medtronic data on file. 10537321DOC, 1060413DOC, 10577687DOC. Heparin washout and fat removal data is from ’30% inlet hematocrit ‘standard wash’ testing.
Blood Facts and Statistics. (n.d.). Retrieved February 15, 2018, from http://www.redcrossblood.org/learn-about-blood/blood-facts-and-statistics.
Shander, A., Hofmann, A., Ozawa, S., Theusinger, O. M., Gombotz, H., & Spahn, D.R. (2010). Activity-based costs of blood transfusions in surgical patients at four hospitals. Transfusion, 50(4), 753–765.
Friedman, R., Homering, M., Holberg, G., & Berkowitz, S. D. (2014). Allogeneic blood transfusions and postoperative infections after total hip or knee arthroplasty. The Journal of Bone and Joint Surgery. American Volume, 96(4), 272–278.
Meybohm, P., Choorapoikayil, S., Wessels, A., Herrmann, E., Zacharowski, K., & Spahn, D. R. (2016). Washed cell salvage in surgical patients. Medicine, 95(31).
Sahu, S., Hemlata, & Verma, A. (2014). Adverse events related to blood transfusion. Indian Journal of Anaesthesia, 58(5), 543–551.
Dionigi, G., Boni, L., Rovera, F., Rausei, S., Cuffari, S., Cantone, G., Bacuzzi, A., Dionigi, R. (2009). Effect of perioperative blood transfusion on clinical outcomes in hepatic surgery for cancer. World Journal of Gastroenterology, 15(32), 3976–3983.